CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in VSTM — Verastem, Inc.

CIK 884546 SAN FRANCISCO, CA

Position in VSTM

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,041,455

-$202,738 QoQ

Shares Held

196,501

+21.9% QoQ

Ownership

0.224%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. VSTM ranks #202 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,920,871	$857,745,736
2	REGN	Regeneron Pharmaceuticals, Inc.	804,508	$621,595,061
3	MRNA	Moderna, Inc.	4,734,356	$240,505,284
4	ALNY	Alnylam Pharmaceuticals, Inc.	673,356	$222,793,299
5	INSM	INSMED Inc	1,069,390	$174,866,652
6	RVMD	Revolution Medicines, Inc.	1,735,476	$168,775,041
7	INCY	Incyte Corp	1,729,102	$162,743,080
8	BBIO	BridgeBio Pharma, Inc.	1,976,094	$146,744,740

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,041,455	196,501	+21.9%	Shares	Sole	2026-05-15
2025-12-31	$1,244,193	161,165	+12.4%	Shares	Sole	2026-02-13
2025-09-30	$1,266,160	143,393	+0.0%	Shares	Sole	2025-11-10
2025-06-30	$594,948	143,361	+21.7%	Shares	Sole	2025-08-12
2025-03-31	$710,237	117,784	+3.7%	Shares	Sole	2025-09-15
2024-12-31	$587,317	113,601	+9.7%	Shares	Sole	2025-02-06
2024-09-30	$309,766	103,601	+46.3%	Shares	Sole	2024-11-12
2024-06-30	$211,013	70,810	+534.6%	Shares	Sole	2024-08-12
2024-03-31	$131,676	11,159	—	Shares	Sole	2024-05-09
No filing history on record for this holder in this stock.